} clin oncol markman m intraperitoneal antineoplastic drug delivery rationale and results lancet oncol markman m intraperitoneal hyperthermic chemotherapy as treatment of peritoneal carcinomatosis of colorectal cancer j atenolol kidney failure clin oncol author reply conti m, de giorgi u, tazzari v, bezzi f atenolol kidney failure and atenolol kidney failure baccini � clinical pharmacology of intraperitoneal cisplatinbased chemotherapy j chemother suppl parker atenolol kidney failure rj, hartman amitriptyine mix mirtazapine kd and sieber sm lymphatic absorption and tissue disposition of liposomeentrapped [c]adriamycin following intraperitoneal administration atenolol kidney failure to rats cancer res parker rj, priester er and sieber sm comparison of lymphatic uptake, metabolism, excretion, and biodistribution atenolol kidney failure of free and liposomeentrapped [c]cytosine betadarabinofuranoside following intraperitoneal administration to rats drug metab dispos rosa atenolol kidney failure p and clementi f absorption and tissue distribution of doxorubicin entrapped in liposomes following intravenous or intraperitoneal administration pharmacology morice p et al are nodal metastases in ovarian cancer chemoresistant lesions?